Products Categories

    Selleck China

    Country: Country China (Mainland)

    Business Type: Trading Company

    qq

  • Ms.Olivia
    Tel: 400-668-6834

  • Mobile:
  • Tel:400-668-6834
  • Fax:
  • Province/state:Shanghai
  • City:Shanghai
  • Street:Building 3, No. 88 Chenhui Road, Kingdee Software Park, Pudong New District, Shanghai, China
  • MaxCard:
Home > Products >  Dabrafenib (GSK2118436)

Dabrafenib (GSK2118436) CAS NO.1195765-45-7

  • Min.Order: 0 Metric Ton
  • Payment Terms:
  • Product Details

Keywords

  • Dabrafenib
  • GSK2118436
  • 1195765-45-7

Quick Details

  • ProName: Dabrafenib (GSK2118436)
  • CasNo: 1195765-45-7
  • Molecular Formula: C23H20F3N5O2S2
  • ProductionCapacity: Metric Ton/Day
  • Purity: >97%
  • LimitNum: 0 Metric Ton

Superiority

Biological Activity

Description Dabrafenib (GSK2118436) is a mutant BRAFV600 specific inhibitor with IC50 of 0.7 nM in cell-free assays, with 7- and 9-fold less potency against B-Raf(wt) and c-Raf, respectively.
Targets
B-Raf (V600E) [3]
(Cell-free assay)		 B-Raf [3]
(Cell-free assay)		 C-Raf [3]
(Cell-free assay)
0.7 nM 5.2 nM 6.3 nM
In vitro

Dabrafenib is selective for Raf kinase, with 400 fold selectivity towards B-Raf over 91% of the other kinases tested. Dabrafenib inhibits B-RafV600E kinase, leading to decreased ERK phosphorylation and inhibition of cell proliferationby an initial arrest in the G1 phase of the cell cycle in cancer cells that specifically encode the mutation for B-RafV600E. [1]
Cell Data
 
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
  Kinase Assay       Inhibition of N-terminal His tagged B-Raf V600E mutant expressed in baculovirus infected insect cells co-expressing CDC37 assessed as decrease in biotinylated-MEK protein phosphorylation by AlphaScreen assay with IC50 of 0.0007 μM 24900673
SK-MEL-28 Kinase Assay   1 h   Inhibition of B-Raf V600E mutant in human SK-MEL-28 cells assessed as decrease in ERK phosphorylation with IC50 of 0.004 μM 24900673
HepG2 Kinase Assay       Inhibition of B-Raf V600E mutant in human HepG2 cells assessed as decrease in ERK phosphorylation with IC50 of 0.004 μM 24900673

... Click to View More Cell Line Experimental Data
Assay
Methods Test Index PMID
Western blot     31158244 24735930 29167314
Growth inhibition assay 24735930
In vivo Dabrafenib (orally administrated) inhibits the growth of B-RafV600E mutant melanoma (A375P) and colon cancer (Colo205) human tumor xenografts, growing subcutaneously in immuno-compromised mice. [1]

 

Details

Other products of this supplier

lookchemhot product CAS New CAS Cas Database Article Data Chemical Catalog